A previous version of this item misstated the date on which publication of the new CME CF Cryptocurrency Pricing Products Family indices would commence. The correct date is as appears below.
The Administrator hereby announces the addition of the below 2 cryptocurrency reference rates to the CME CF Cryptocurrency Pricing Products Family:
Each reference rate will publish the U.S. dollar price of each digital asset once a day at 16:00 Hong Kong time and will be subject to CME CF Reference Rates Methodology rules.
Publication of these reference rates will commence on September 11th, 2023.
For licensing enquiries please contact [email protected]
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
Regulatory clarity is poised to support digital assets despite macro headwinds. The GENIUS Act greenlights USD stablecoins, while the SEC moves to fast-track multi-token spot ETFs. Corporate treasuries may add ETH and SOL, as tokenized equities lift block demand and staking yields.
Gabriel Selby
We're excited to launch CF Factor Intelligence - the First Institutional-Grade Factor Model for Digital Assets. Backed by our industry-leading research, this represents a groundbreaking addition to our product suite. It's a data product suite providing a toolkit to explain digital asset returns.
CF Benchmarks
REX-Osprey Solana + Staking ETF (SSK) is the first ETF to deliver spot Solana (SOL) exposure alongside direct, on-chain staking rewards in a regulated investment vehicle.
CF Benchmarks